|
English
|
正體中文
|
简体中文
|
總筆數 :2875232
|
|
造訪人次 :
54169174
線上人數 :
1143
教育部委託研究計畫 計畫執行:國立臺灣大學圖書館
|
|
|
顯示項目 561041-561050 / 2351377 (共235138頁)
<< < 56100 56101 56102 56103 56104 56105 56106 56107 56108 56109 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2020-11-30T07:35:55Z |
Lung adenocarcinoma and human papillomavirus infection
|
Chen Y.-C.;Jen-Hau Chen;Richard K.;Chen P.-Y.;Christiani D.C.; Chen Y.-C.; JEN-HAU CHEN; Richard K.; Chen P.-Y.; Christiani D.C. |
| 臺北醫學大學 |
2015-12 |
lung adenocarcinoma of Iressa
|
曾怡文 |
| 臺大學術典藏 |
2018-09-10T18:04:09Z |
Lung adenocarcinoma patients of young age have lower EGFR mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitors
|
Wu, S.-G. and Chang, Y.-L. and Yu, C.-J. and Yang, P.-C. and Shih, J.-Y.; YIH-LEONG CHANG; Chong-Jen Yu; JIN-YUAN SHIH |
| 臺大學術典藏 |
2017 |
Lung adenocarcinoma patients of young age have lower EGFR mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitors
|
Wu S.-G.;Yih-Leong Chang;Yu C.-J.;Yang P.-C.;Shih J.-Y.; Wu S.-G.; YIH-LEONG CHANG; Yu C.-J.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-03-06T05:26:05Z |
Lung adenocarcinoma patients of young age have lower EGFR mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitors
|
Wu S.-G.; YIH-LEONG CHANG; Yu C.-J.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2022-06-27T07:00:08Z |
Lung adenocarcinoma patients of young age have lower EGFR mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitors
|
Wu S.-G.; Chang Y.-L.; CHONG-JEN YU; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2022-09-08T08:16:43Z |
Lung adenocarcinoma patients of young age have lower EGFR mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitors
|
Wu, Shang-Gin; Chang, Yih-Leong; Yu, Chong-Jen; PAN-CHYR YANG; Shih, Jin-Yuan |
| 國立臺灣大學 |
2008 |
Lung Adenocarcinoma with Good Response to Erlotinib after Gefitinib Treatment Failure and Acquired T790m Mutation
|
吳尚俊; 施金元; 余忠仁; 楊泮池; WU, SHANG-GIN; SHIH, JIN-YUAN; YU, CHONG-JEN; YANG, PAN-CHYR |
| 臺大學術典藏 |
2018-09-10T06:47:49Z |
Lung adenocarcinoma with good response to erlotinib after gefitinib treatment failure and acquired T790M mutation
|
Wu, S.-G. and Shih, J.-Y. and Yu, C.-J. and Yang, P.-C.; Chong-Jen Yu; JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-08-12T08:25:32Z |
Lung adenocarcinoma with good response to erlotinib after gefitinib treatment failure and acquired T790M mutation
|
SHANG-GIN WU; Shih J.-Y.; Yu C.-J.; Yang P.-C. |
顯示項目 561041-561050 / 2351377 (共235138頁)
<< < 56100 56101 56102 56103 56104 56105 56106 56107 56108 56109 > >>
每頁顯示[10|25|50]項目
|
